Package 81005-104-01

{"route": ["ORAL"], "spl_id": "45753e50-34f0-97e1-e063-6394a90abd3d", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0381005105014", "0381005105106", "0381005104109"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["ddfd44dc-3136-4dda-8ed0-eb2991c2a0b6"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Aarkish Pharmaceuticals NJ Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (81005-104-01)", "package_ndc": "81005-104-01", "marketing_start_date": "20241203"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (81005-104-10)", "package_ndc": "81005-104-10", "marketing_start_date": "20241203"}], "brand_name": "Acetazolamide", "product_id": "81005-104_45753e50-34f0-97e1-e063-6394a90abd3d", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "81005-104", "generic_name": "Acetazolamide", "labeler_name": "Aarkish Pharmaceuticals NJ Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "125 mg/1"}], "application_number": "ANDA217197", "marketing_category": "ANDA", "marketing_start_date": "20241203", "listing_expiration_date": "20261231"}